Papillon-Lefévre syndrome: The response to acitretin

International Journal of Dermatology

Volumn 41, Issue 12, 2002, Pages 938-941

  Al Khenaizan, Sultan ^a  

^a KING FAHAD NATIONAL GUARD HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

EMOLLIENT AGENT; ETRETIN; SALICYLIC ACID; UREA;

AUTOSOMAL RECESSIVE DISORDER; BODY WEIGHT; CASE REPORT; CONFERENCE PAPER; DECIDUOUS TOOTH; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG TOLERABILITY; DRUG USE; ERYTHEMA; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; KERATOSIS PALMOPLANTARIS; MAINTENANCE THERAPY; PERIODONTITIS; PHYSICAL EXAMINATION; PRESCHOOL CHILD; SIDE EFFECT; WINTER;

ACITRETIN; CHILD, PRESCHOOL; FEMALE; HUMANS; KERATOLYTIC AGENTS; PAPILLON-LEFEVRE DISEASE;

EID: 0036941999     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2002.01664_3.x     Document Type: Conference Paper

References (30)

1. Gorlin RJ, Sedano H, Anderson VE. The syndrome of palmar-plantar hyperkeratosis and premature periodontal destruction of the teeth. J Pediatr 1964; 65: 895-908.
2. Hattab FN, Rawashdeh MA, Yassin OM, Al-Momani AS, Al-Ubosi MM. Papillon-Lefevre syndrome. A review of the literature and report of 4 cases. J Periodontol 1995; 66: 413-420.
3. Papillon M, Lefevre P. Dens cas de keratodermie palmaire et plantaire symetrique familale (maladie de meleda) chez le frere soeur: co edistence dans les deux cas d'alterations dentaires groups. Bull Soc Fr Dermatol Syph 1924; 31: 82-87.
4. Oguzkurt P, Tanyel FC, Buyukpamukeu N, Hicsonmez A. Increased risk of pyogenic liver abscess in children with Papillon-Lefévre syndrome. J Pediatr Surg 1996; 31: 955-956.
5. Tosti A, Manuzzi P, Bardazzi F, Costa A. Is etretinate dangerous in Papillon-Lefévre syndrome? Dermatologica 1988; 176: 148-150.
6. Kellum R. Papillon-Lefévre syndrome in four siblings treated with etretinate: A nine-year evaluation. Int J Dermatol 1989; 28: 605-608.
7. Driban NE, Jung JR. Papillon-Lefevre syndrome. A clinical and therapeutical contribution. Dermatologica 1982; 165: 653-659.
8. Van Dyke TE, Taubman MA, Ebersole JL, Haffajee AD, Socransky SS, Smith DJ, Genco RJ. The Papillon-Lefevre syndrome: Neutrophil dysfunction with severe periodontal disease. Clin Immunol Immunopathol 1984; 31: 419-429.
9. Siragusa M, Romano C, Batticane N, Batolo D, Schepis C. A new family with Papillon-Lefévre syndrome: Effectiveness of etretinate treatment. Cutis 2000; 65: 151-155.
10. Harrington E, Bleicher MA. Cryptogenic hepatic abscess in two uncompromised children. J Pediatr Surg 1980; 15: 660-662.
11. Adriaens PA. Bacterial invasion in periodontitis, is it important in periodontal treatment? Ref Blge Med Dent 1989; 44: 9-30.
12. Umeda M, Zhang YJ, Koseki T, Ishikawa I. Clinical, bacteriological and immunological examination and treatment of two Papillon-Lefevre syndrome patients. Kokubyo Gakkai Zasshi 1990; 57: 430-440.
13. Ishikawa I, Umeda M, Laosrisin N. Clinical, bacteriological, and immunological examinations and the treatment process of Papillon-Lefevre syndrome patients. J Periodontol 1994; 65: 364-371.
14. Haneke E, Homstein OP, Lex C. Increased susceptibility to infections in the Papillon-Lefevre syndrome. Dermatologica 1975; 150: 283-286.
15. Haim S, Munk J. Keratosis palmo-plantar congenita with periodontosis, arachnedactyly and a peculiar deformity of the terminal phalanges. Br J Dermatol 1965; 77: 42-53.
16. Bravo-Piris J, Aparicio M, Moran M, Armijo M. Papillon-Lefevre syndrome: Report of a case treated with oral retinoid RO 10-9359. Dermatologica 1983; 166: 97-103.
17. Bergman R, Friedman-Birnbaum R. Papillon-Lefevre syndrome: A study of the long-term clinical course of recurrent pyogenic infections and the effects of etretinate treatment. Br J Dermatol 1988; 119: 731-736.
18. Khandpur S, Reddy BS. Papillon-Lefevre syndrome with pyogenic hepatic abscess: A rare association. Pediatr Dermatol 2000; 18: 45-47.
19. El Darouti MA, Al Raubie SM, Eiada MA. Papillon-Lefevre syndrome. Successful treatment with oral retinoids in three patients. Int J Dermatol 1988; 27: 63-66.
20. Gelmetti C, Nazzaro V, Cerri D, Fracasso L. Long term preservation of permanent teeth in a patient with Papillon-Lefevre sydnrome treated with etretinate. Pediatr Dermatol 1989; 6: 222-225.
21. Nguyen TQ, Greer KE, Fisher GB Jr, Cooper PH. Papillon-Lefevre syndrome. Report of two patients treated successfully with isotretinoin. J Am Acad Dermatol 1986; 15: 638-641.
22. Nazzaro V, Blanchet-Bardon C, Mimoz C, Revuz J, Puissant A. Papillon-Lefevre syndrome. Ultrastructural study and successful treatment with acitretin. Arch Dermatol 1988; 124: 533-539.
23. Blanchet-Bardon C, Nazzaro V, Rognin C, Geiger JM, Puissant A. Acitretin in the treatment of severe disorder of keratinization. Results of an open study. J Am Acad Dermatol 1999; 24: 982-986.
24. Preus HR. Treatment of rapidly destructive periodontitis in Papillon-Lefevre syndrome. Laboratory and clinical osbervations. J Clin Periodontol 1988; 15: 639-643.
25. Kim JB, Morita M, Kusumoto M, Watanabe T, Takagi S, Nishijima K. Preservation of permanent teeth in a patient with Papillon-Lefevre syndrome by professional tooth-cleaning. ASDC J Dent Child 1997; 64: 222-226.
26. Fischer J, Blanchet-Bardon C, Prud'homme JF, et al. Mapping of Papillon-Lefevre syndrome to the chromosome 11q14 region. Eur J Hum Genet 1997; 5: 156-160.
27. Hart TC, Bowden DW, Ghaffar KA, et al. Sublocalization of the PLS, locus on 11g 14-g 21. AmJ Med Genet 1998; 79: 134-139.
28. Hart TC, Hart PS, Bowden DW, et al. Mutations of the cathepsin C gene are responsible for Papillon-Lefévre Syndrome. J Med Genet 1999; 36: 881-887.
29. Gorlin RJ. Of palms soles, and gums. J Med Genet 2000; 37: 81-82.
30. Hart TC, Hart PS, Michalec MD, et al. Localization of a gene for prepubertal periodontitis to chromosome 11q14 andn identification of a cathepsin C gene mutation. J Med Genet 2000; 37: 81-82.